Filing Flows › Nexgel (NXGL) › Q2 2026 › vs Q1 2026
Nexgel (NXGL) Q2 2026 vs Q1 2026 (quarter over quarter)
Nexgel's revenue rose $1.0M (+39%) from $2.6M in Q1 2026 to $3.7M in Q2 2026.
Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%, net loss $3.6M, operating cash flow −$2.2M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $3.7M | $2.6M | $1.0M | +39% |
| Net loss | $3.6M | $871K | $2.7M | +314% |
| Costs & expenses | $7.3M | $3.6M | $3.7M | +102% |
| Operating costs | $6.2M | $3.6M | $2.6M | +72% |
| Interest & other, net | $1.1M | −$87K | $1.2M | — |
| Cost of revenue | $2.6M | $1.6M | $988K | +62% |
| Operating cash sources | $3.6M | $871K | $2.7M | +314% |
| Depreciation & amortization | $827K | $99K | $728K | +735% |
| Share-based compensation | $119K | $143K | −$24K | -17% |
| Working capital & other | $463K | $125K | $338K | +270% |
| Cash used in operations | $2.2M | $504K | $1.7M | +336% |
| Net loss absorbed | $3.6M | $871K | $2.7M | +314% |
Questions
How much did Nexgel's revenue grow quarter over quarter in Q2 2026?
Nexgel's revenue rose $1.0M (+39%) from $2.6M in Q1 2026 to $3.7M in Q2 2026.